Sentence examples for comparison of decisions from inspiring English sources

When multiple decisions matching these criteria existed for a particular drug-indication combination for a given agency, the first such decision was chosen for inclusion in the analysis to enable comparison of decisions based on the existing body of data without changing recommendations over time based on other external factors (pricing negotiations between the HTA body and the manufacturer).

In this work, we propose a fuzzy AHP variant, wherein pairwise comparison of decision elements by domain experts is expressed with triangular fuzzy numbers.

FAHP is an extension of classical Analytic Hierarchy Process (AHP) approach where it uses triangular fuzzy numbers instead of exact numerical values to express the pairwise comparison of decision elements.

The groups facilitated comparison of decision-making processes among the groups as well as perceptions of outcomes.

Since most journals use similar or identical online submission systems where metadata can easily be retrieved, a transparent comparison of decision times is feasible.

Stage 3: The identification of the relative contribution of factors to the assessment and the decision and comparison of decision threshold levels through completion of the vignette task created in stage 2 (research questions 2 5).

First, the study was conducted with simulated patients; the simulations were based on real cases but for this systematic comparison of decision making with and without decision support ethical and practical constraints forced us to use computer-based presentation of patient data rather than real patients.

CR value greater than 0.10 means that either a calculation mistake in the model or inconsistency of the comparisons of decision maker.

The comparison of soft-decision LDPC and hard-decision BCH codes clearly shows the advantage of the soft-decision decoding.

The decision tree outlined in Figure 1 was constructed to allow comparison of a decision to manage patients with a CPU or to use routine care.

Due to that a comparison of HTA-decisions across Europe for new pharmaceutical products is not feasible.